{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:44:34Z","timestamp":1793504674476,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["09SDG2250647"],"award-info":[{"award-number":["09SDG2250647"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ahj.2023.03.015","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T11:15:37Z","timestamp":1680693337000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Association of CHA2DS2-VASc and HAS-BLED to frailty and frail outcomes: From the TREAT-AF study"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1230-367X","authenticated-orcid":false,"given":"Krishna","family":"Pundi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Perino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Szummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu P.","family":"Turakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.03.015_bib0001","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrcardio.2016.114","article-title":"Global epidemiology of atrial fibrillation","volume":"13","author":"Rahman","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0002","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.03.015_bib0003","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.03.015_bib0004","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/heartjnl-2013-305303","article-title":"Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores","volume":"100","author":"Mitchell","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2023.03.015_bib0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0b013e318287281b","article-title":"CHA\u2082S\u2082DS\u2082-VASc, and long-term stroke outcome in patients without atrial fibrillation","volume":"80","author":"Ntaios","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ahj.2023.03.015_bib0006","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ahj.2023.03.015_bib0007","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/ggi.13058","article-title":"Clinical frailty is independently associated with non-prescription of anticoagulants in older patients with atrial fibrillation","volume":"17","author":"Induruwa","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.ahj.2023.03.015_bib0008","first-page":"169","article-title":"The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF study","volume":"32","author":"Lefebvre","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afn293","article-title":"The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation","volume":"38","author":"Perera","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.ahj.2023.03.015_bib0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","article-title":"Development of a claims-based frailty indicator anchored to a well-established frailty phenotype","volume":"55","author":"Segal","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2023.03.015_bib0011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1020579806511","article-title":"Using administrative databases for outcomes research: select examples from VA Health Services Research and Development","volume":"23","author":"Cowper","year":"1999","journal-title":"J Med Syst"},{"key":"10.1016\/j.ahj.2023.03.015_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/1077558703256726","article-title":"Pharmacy data in the VA health care system","volume":"60","author":"Smith","year":"2003","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.ahj.2023.03.015_bib0013","series-title":"VIReC Research User Guide: VHA Decision support System Clinical National Data Extracts. Hines, IL: US Dept. of Veterans Affairs, Health Services Research and Development Service","year":"2009"},{"key":"10.1016\/j.ahj.2023.03.015_bib0014","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.mlr.0000244657.90074.b7","article-title":"Veterans\u2019 access to and use of medicare and veterans affairs health care","volume":"45","author":"Hynes","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2023.03.015_bib0015","series-title":"VIReC Technical Report 2: VANDI Mortality Data Merge Project","author":"Arnold","year":"2006"},{"issue":"2","key":"10.1016\/j.ahj.2023.03.015_bib0016","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.ahj.2023.03.015_bib0017","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2014.03.060","article-title":"Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study","volume":"64","author":"Turakhia","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0018","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacc.2017.04.054","article-title":"Treating specialty and outcomes in newly diagnosed atrial fibrillation: from the TREAT-AF study","volume":"70","author":"Perino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2015.07.023","article-title":"Amiodarone and risk of death in contemporary patients with atrial fibrillation: findings from the retrospective evaluation and assessment of therapies in AF study","volume":"170","author":"Ullal","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.03.015_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.10.010","article-title":"Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: the retrospective evaluation and assessment of therapies in AF (TREAT-AF) study","volume":"165","author":"Turakhia","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.03.015_bib0021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/pds.3674","article-title":"Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations","volume":"23","author":"Kim","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ahj.2023.03.015_bib0022","doi-asserted-by":"crossref","first-page":"706","DOI":"10.7326\/M17-0767","article-title":"Concentration of Potentially Preventable Spending Among High-Cost Medicare Subpopulations: An Observational Study","volume":"167","author":"Figueroa","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2023.03.015_bib0023","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jacc.2017.06.024","article-title":"Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study","volume":"70","author":"Afilalo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0024","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.116.09390","article-title":"Blood pressure, antihypertensive polypharmacy, frailty, and risk for serious fall injuries among older treated adults with hypertension","volume":"70","author":"Bromfield","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2023.03.015_bib0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1532-5415.2009.02137.x","article-title":"A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men","volume":"57","author":"Ensrud","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ahj.2023.03.015_bib0026","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1532-5415.2004.52521.x","article-title":"Operationalizing a frailty index from a standardized comprehensive geriatric assessment","volume":"52","author":"Jones","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ahj.2023.03.015_bib0027","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archinternmed.2007.113","article-title":"Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women","volume":"168","author":"Ensrud","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2023.03.015_bib0028","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/gerona\/62.7.744","article-title":"Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures","volume":"62","author":"Ensrud","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ahj.2023.03.015_bib0029","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCEP.114.003057","article-title":"Atrial fibrillation burden and short-term risk of stroke: case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices","volume":"8","author":"Turakhia","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007604","article-title":"Site variation and outcomes for antithrombotic therapy in atrial fibrillation patients after percutaneous coronary intervention","volume":"12","author":"Olivier","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.03.015_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.116.024057","article-title":"Wide variation in reported rates of stroke across cohorts of patients with atrial fibrillation","volume":"135","author":"Quinn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.03.015_bib0032","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.03.015_bib0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2023.03.015_bib0034","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4022\/jafib.1870","article-title":"What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? a systematic review and meta-analysis","volume":"10","author":"Oqab","year":"2018","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.ahj.2023.03.015_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2019.01.005","article-title":"Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation","volume":"211","author":"Madhavan","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.03.015_bib0036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ahj.2018.03.003","article-title":"Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk","volume":"200","author":"Lubitz","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.03.015_bib0037","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.hrthm.2022.01.007","article-title":"Frailty in patients undergoing percutaneous left atrial appendage closure","volume":"19","author":"Wang","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2023.03.015_bib0038","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.03.015_bib0039","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S0735-1097(02)02776-6","article-title":"Oral anticoagulants in patients with coronary artery disease","volume":"41","author":"Anand","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jjcc.2018.01.015","article-title":"Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: a systematic review and meta-analysis","volume":"72","author":"Kim","year":"2018","journal-title":"J Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0041","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.113.005008","volume":"130","author":"Halperin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.03.015_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.118.008643","article-title":"Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in frail patients with nonvalvular atrial fibrillation","volume":"7","author":"Martinez","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.03.015_bib0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2018.09.017","article-title":"Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial","volume":"208","author":"Alexander","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.03.015_bib0044","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","article-title":"Management of atrial fibrillation in patients 75 years and older","volume":"79","author":"Volgman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.03.015_bib0045","doi-asserted-by":"crossref","DOI":"10.1007\/s11845-021-02891-x","article-title":"Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people","author":"Erdem","year":"2022","journal-title":"Ir J Med Sci [Internet]"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:09:53Z","timestamp":1757570993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":45,"alternative-id":["S0002870323000765"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.03.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of CHA2DS2-VASc and HAS-BLED to frailty and frail outcomes: From the TREAT-AF study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}